AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takayasu, K.
Right arrow Articles by Ueno, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takayasu, K.
Right arrow Articles by Ueno, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Targeted Transarterial Oily Chemoembolization for Small Foci of Hepatocellular Carcinoma Using a Unified Helical CT and Angiography system

Analysis of Factors Affecting Local Recurrence and Survival rates

Kenichi Takayasu1, Yoshihisa Muramatsu1, Tetsuo Maeda1, Ryoko Iwata1, Hiroyoshi Furukawa1, Yukio Muramatsu1, Noriyuki Moriyama1, Takuji Okusaka2, Shuichi Okada2 and Hideki Ueno2

1 Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
2 Department of Internal Medicine, National Cancer Center Hospital, Tokyo 104-0045, Japan.



View larger version (78K):

[in a new window]
 
Fig. 1A. 81-year-old woman with hepatocellular carcinoma between segments II and III. CT scan during arterial portography reveals perfusion defect (arrow). Note that in right lobe previously treated lesion contains deposition of iodized oil.

 


View larger version (115K):

[in a new window]
 
Fig. 1B. 81-year-old woman with hepatocellular carcinoma between segments II and III. Left hepatic angiogram shows faint tumor staining (short arrows) supplied from two feeder arteries, one (long arrow) from left lateral superior branch and the other (arrowhead) from inferior branch. Latter artery was not suspected as feeder at this angiographic study.

 


View larger version (105K):

[in a new window]
 
Fig. 1C. 81-year-old woman with hepatocellular carcinoma between segments II and III. CT arteriogram of B shows targeted lesion (arrow) and noncancerous hepatic portion to be embolized.

 


View larger version (150K):

[in a new window]
 
Fig. 1D. 81-year-old woman with hepatocellular carcinoma between segments II and III. Angiogram shows microcatheter being advanced to more distal branch artery that is shown as long arrow in B.

 


View larger version (101K):

[in a new window]
 
Fig. 1E. 81-year-old woman with hepatocellular carcinoma between segments II and III. CT arteriogram of D shows lesion and noncancerous area to be embolized as smaller than that seen in C. Ventral portion of lesion is incompletely enhanced, suggesting another feeding artery.

 


View larger version (135K):

[in a new window]
 
Fig. 1F. 81-year-old woman with hepatocellular carcinoma between segments II and III. Superselective angiogram shows another feeding artery derived from origin of left lateral inferior branch. Note tumor stain (arrows).

 


View larger version (102K):

[in a new window]
 
Fig. 1G. 81-year-old woman with hepatocellular carcinoma between segments II and III. CT arteriogram of F shows ventral defect of tumor, which is now enhanced. Oily chemoembolization was performed.

 


View larger version (98K):

[in a new window]
 
Fig. 1H. 81-year-old woman with hepatocellular carcinoma between segments II and III. Unenhanced CT scan shows good retention of iodized oil in entire tumor and in surrounding hepatic parenchyma. CT arteriography of right hepatic artery is simultaneously performed to evaluate effect of previous oily chemoembolization.

 


View larger version (9K):

[in a new window]
 
Fig. 2. Overall local recurrence rate for 71 small hepatocellular carcinomas (<=5 cm) with one session of oily chemoembolization with unified helical CT angiography system. Local recurrence rate is 33.2% at 1 year and 37.8% at 2 and 3 years. TOCE = transarterial oily chemoembolization.

 


View larger version (14K):

[in a new window]
 
Fig. 3. Local recurrence rates in relation to tumor size. Two-year local recurrence rate was 15%, 40%, and 61% for small (<= 1 cm), medium (1-2.5 cm) and large (2.5-5 cm) groups, respectively. TOCE = transarterial oily chemoembolization.

 


View larger version (9K):

[in a new window]
 
Fig. 4. Graph shows survival rates at 1, 2, and 3 years after treatment in 54 patients with 71 hepatocellular carcinomas. Note that 1- and 3- year survival rates were 93.3% and 77.1%, respectively. TOCE = transarterial oily chemoembolization.

 


View larger version (125K):

[in a new window]
 
Fig. 5A. 57-year-old man undergoing misembolization for hepatocellular carcinoma by conventional subsegmental oily chemoembolization. Radiograph after oily chemoembolization of anterior superior branch discloses good accumulation of iodized oil in targeted lesion (arrows) and accompanying portal veins.

 


View larger version (133K):

[in a new window]
 
Fig. 5B. 57-year-old man undergoing misembolization for hepatocellular carcinoma by conventional subsegmental oily chemoembolization. Dynamic CT scan, obtained 1 week after A, shows dense deposition of iodized oil not in targeted lesion but in noncancerous hepatic portion just posterior to well-opacified hepatocellular carcinoma (arrow) with faint iodized oil deposition. Ascites has appeared anew on liver surface.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Roentgen Ray Society.